Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
•
Dermatology
Do you adjust PSA for finasteride use when determining prostate cancer stage and risk category?
If this upstages the patient, do you modify treatment recommendations?
Answer from: Radiation Oncologist at Community Practice
We generally use the rule of 50% (real PSA is twice the lab value when on Finasteride).
Sign in or Register to read more
7534
Related Questions
In asymptomatic patients with castrate resistant prostate cancer who have failed chemotherapy and have progressive PSMA-avid vertebral body metastases, when do you prescribe lutetium 177 (Pluvicto) vs prophylactic spinal radiation?
How would you approach de novo metastatic castrate sensitive prostate cancer with extensive locoregional spread causing rectal compression, retroperitoneal lymphadenopathy, and PSA >3000 but no visceral or bone metastases?
Is there any way to safely treat patients with mCRPC with 177-Lu PSMA who are on hemodialysis?
Given results of the RADICALS trials, is LT-ADT standard of care for salvage prostate RT?
Is there any evidence for amyloid/amyloidosis causing a spurious/false PSA reading?
What are your top takeaways from ASCO GU 2024?
If a patient diagnosed with seminoma after orchiectomy has margin positive disease noted in the spermatic cord and no overt metastasis on imaging and normal tumor markers, how should this patient be staged?
How would you plan sequencing of an MRI-directed prostate nodule micro-boost when doing a sequential plan?
Which genomic test do you choose for a patient with favorable intermediate prostate cancer trying to decide between active surveillance and treatment?
How do you contour your elective obturator lymph node volume?